Otto Ettala
otolet@utu.fi |
- Reply to Joshua S. Jue and Mahmoud Alameddine's Letter to the Editor re: Juha Knaapila, Ivan Jambor, Ileana Montoya Perez, et al. Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study (2019)
- European Urology Oncology
- Urine cytology is a feasible tool for assessing erythematous bladder lesions after bacille Calmette-Guérin (BCG) treatment (2019)
- BJU International
- Validation of IMPROD biparametric MRI in men with clinically suspected prostate cancer: A prospective multi-institutional trial (2019)
- PLoS Medicine
- ANO7 is associated with aggressive prostate cancer (2018)
- International Journal of Cancer
- Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: A prospective, registered, multicentre study (2018)
- BJU International
- C-11-acetate PET/MRI in bladder cancer staging and treatment response evaluation to neoadjuvant chemotherapy: a prospective multicenter study (ACEBIB trial) (2018)
- Cancer Imaging
- Intratumoral androgen levels are linked to TMPRSS2-ERG fusion in prostate cancer (2018)
- Endocrine-Related Cancer
- Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrspective Nationwide Study (2018)
- European Urology Oncology
- Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings (2018)
- Journal of Magnetic Resonance Imaging
- Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer (2018)
- Clinical Cancer Research



